ArQule Inc. (ARQL) Stock Quote

Detailed Quote for ArQule Inc. (ARQL)

close 52 Week Information

52 Week High

February 3, 2012

Close: 8.19

52 Week Low

September 6, 2011

Close: 3.98

Today

5d

1m

3m

1y

more

Last Price
7.77

Change $
0.10

Change %
1.27%

Tick

Bid
7.75

Bid Size
600

Ask
7.77

Ask Size
200

Open
7.81

High
7.84

Low
7.73

Prev Close
7.87

Last Trade
2:10

Volume
162.75 k

52 Wk Hi
8.19

52 Wk Low
3.98

Market Cap
417.81 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
53,772,710

EPS (TTM)
-0.40

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for ArQule Inc. (ARQL)

Sector News | Topic News

News for ARQL

Thu, Feb 09, 2012

8:30 AM

ArQule, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference - Business Wire

Tue, Jan 17, 2012

7:30 AM

ArQule Announces Tivantinib Meets Primary Endpoint, Significantly Extending Time to Progression in Phase 2 Trial in Second-Line Hepatocellular Carcinoma - Business Wire

Tue, Dec 06, 2011

8:30 AM

ArQule, Inc. to Present at Oppenheimer 22nd Annual Healthcare Conference - Business Wire

Thu, Sep 22, 2011

9:01 AM

Global Situation & Resulting Influences - Research Report on ArQule, Inc. and Exelixis, Inc. - Marketwire

More News for ARQL >>

Tags for ArQule Inc.

Research stocks or mutual funds related to ArQule Inc. by keywords or tags. Find companies that have a similar focus to ARQL. The keywords below have been associated to ARQL by either user submission or electronic means.

pharmaceutical sales data biotechnology company clinical trials database biotech research clinical trial logistics clinical trial enrollment clinical trials liability clinical research trial clinical research software pharmaceutical branding clinical trials data pharmaceutical market pharmaceuticals clinical trials safety studies niche pharmaceutical breach of contract law jobs in pharmaceutical clinical pharmacology pharmaceutical research and development laser hair removal pharmaceutical supplies dendreon pharma marketing clinical trials uk business contract law pharmaceutical software pharmaceuticals jobs phase iii clinical trials romania clinical research novartis pharmaceuticals gmp pharmaceutical biotechnology jobs clinical research enrollment clinical trials pharmaceutical ingredients pharma companies active pharmaceutical ingredients pharmaceutical sales paid clinical trial phase 3 clinical trials clinical trial phases clinical trials directive pharma clinical trials manager fda clinical trial pharmaceutical distributors european clinical trials medical research clinical trials design biotech corporation

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.